LILLY DRN
Eli Lilly weight loss drug Zepbound no longer in shortage
Craig Fedirighi
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. ...
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
Mickey Vernon
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March ...
Merck signs weight loss pill licensing deal with Hansoh Pharma
Craig Fedirighi
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty ...
Weight-loss drug boom has become one of the internet’s biggest scams
John Ray
A production line of Wegovy injection pens for the Asian market at the Novo Nordisk A/S pharmaceutical manufacturing facility in ...
Here’s what can go right to lift each of our 34 portfolio stocks
Albert Wagner
Sometimes, there can be an overwhelming amount of negativity and noise on Wall Street. To counter that, Jim Cramer has ...
Amgen says obesity drug MariTide caused up to 20% weight loss after a year
Craig Fedirighi
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty ...
/cdn.vox-cdn.com/uploads/chorus_asset/file/22481672/acastro_210430_1777_semiCon_0001.jpg?w=150&resize=150,150&ssl=1 "The US finalizes CHIPS Act funding for Samsung and Texas Instruments")
/cdn.vox-cdn.com/uploads/chorus_asset/file/25796565/1963152043.jpg?w=150&resize=150,150&ssl=1 "Biden administration passes the torch to local leaders to keep climate action alive")